Orthopediatrics Corp (KIDS) Expected to Post Quarterly Sales of $11.45 Million

Equities research analysts expect Orthopediatrics Corp (NASDAQ:KIDS) to post sales of $11.45 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Orthopediatrics’ earnings, with the lowest sales estimate coming in at $11.30 million and the highest estimate coming in at $11.60 million. The business is scheduled to report its next earnings report on Wednesday, February 14th.

According to Zacks, analysts expect that Orthopediatrics will report full-year sales of $11.45 million for the current financial year, with estimates ranging from $45.20 million to $45.50 million. For the next fiscal year, analysts anticipate that the firm will report sales of $54.70 million per share, with estimates ranging from $54.40 million to $55.00 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that cover Orthopediatrics.

Orthopediatrics (NASDAQ:KIDS) last announced its earnings results on Wednesday, November 8th. The company reported ($1.70) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($1.58).

Several analysts have issued reports on KIDS shares. Stifel Nicolaus started coverage on shares of Orthopediatrics in a research note on Monday, November 6th. They set a “buy” rating and a $23.00 target price on the stock. BTIG Research started coverage on shares of Orthopediatrics in a research note on Monday, November 6th. They set a “buy” rating and a $24.00 target price on the stock. William Blair started coverage on shares of Orthopediatrics in a research note on Monday, November 6th. They set an “outperform” rating on the stock. Piper Jaffray Companies started coverage on shares of Orthopediatrics in a research note on Monday, November 6th. They set an “overweight” rating and a $24.00 target price on the stock. Finally, BidaskClub downgraded shares of Orthopediatrics from a “hold” rating to a “sell” rating in a research note on Tuesday, January 9th. Two analysts have rated the stock with a sell rating and four have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $23.67.

An institutional investor recently bought a new position in Orthopediatrics stock. Kornitzer Capital Management Inc. KS purchased a new position in Orthopediatrics Corp (NASDAQ:KIDS) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 20,000 shares of the company’s stock, valued at approximately $384,000. Kornitzer Capital Management Inc. KS owned about 0.16% of Orthopediatrics at the end of the most recent quarter. Hedge funds and other institutional investors own 1.28% of the company’s stock.

Shares of Orthopediatrics (NASDAQ KIDS) opened at $17.03 on Friday. The company has a debt-to-equity ratio of -0.38, a current ratio of 2.78 and a quick ratio of 1.00. Orthopediatrics has a one year low of $16.01 and a one year high of $23.00.

ILLEGAL ACTIVITY NOTICE: This piece was originally published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2018/02/04/orthopediatrics-corp-kids-expected-to-post-quarterly-sales-of-11-45-million.html.

Orthopediatrics Company Profile

OrthoPediatrics Corp. is a medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.

Get a free copy of the Zacks research report on Orthopediatrics (KIDS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply